Tag: Hatch-Waxman
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
30 Dec 2025
Desensitization Protocols for Medication Side Effects: When They’re Used
-
11 Jul 2025
Choosing the Right Antifungal Cream for Toddler Skin: Tips, Safety, and Facts
-
1 Feb 2026
Managing Multiple Medications: How to Reduce Drug Interactions and Stay Safe
-
23 Jun 2025
Lithium: What It Is, How It Works, and Why It’s Essential for Mental Health
-
20 Jan 2026
Online Pharmacy Counterfeits: How Fake Medicines Put Your Life at Risk